Immunotherapy clinical trial aims to combat brain cancer – Packet Online
|
Immunotherapy clinical trial aims to combat brain cancer
Packet Online “The Phase 1 results of this promising immunotherapy reported a 40 percent probability of survival at two years for patients with recurrent glioblastoma,” Dr. Moshel continues. “It's been very hard to get these kinds of results with such an aggressive … |
